DIAFORA MEDICAL LIMITED

DIAFORA MEDICAL LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameDIAFORA MEDICAL LIMITED
    Company StatusDissolved
    Legal FormPrivate limited company
    Company Number 13626710
    JurisdictionEngland/Wales
    Date of Creation
    Date of Cessation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of DIAFORA MEDICAL LIMITED?

    • Other research and experimental development on natural sciences and engineering (72190) / Professional, scientific and technical activities

    Where is DIAFORA MEDICAL LIMITED located?

    Registered Office Address
    203 Fulham Road
    SW3 6JJ London
    United Kingdom
    Undeliverable Registered Office AddressNo

    What are the latest accounts for DIAFORA MEDICAL LIMITED?

    Last Accounts
    Last Accounts Made Up ToDec 31, 2022

    What is the status of the latest confirmation statement for DIAFORA MEDICAL LIMITED?

    Last Confirmation Statement
    Next Confirmation Statement Made Up ToSep 11, 2023

    What are the latest filings for DIAFORA MEDICAL LIMITED?

    Filings
    DateDescriptionDocumentType

    Final Gazette dissolved via voluntary strike-off

    1 pagesGAZ2(A)

    Voluntary strike-off action has been suspended

    1 pagesSOAS(A)

    First Gazette notice for voluntary strike-off

    1 pagesGAZ1(A)

    Application to strike the company off the register

    2 pagesDS01

    Appointment of Mrs Karolina Zaremba-Tymieniecka as a director on May 22, 2024

    2 pagesAP01

    Termination of appointment of Marcus James Thorman as a director on May 10, 2024

    1 pagesTM01

    Confirmation statement made on Sep 11, 2023 with updates

    4 pagesCS01

    Unaudited abridged accounts made up to Dec 31, 2022

    10 pagesAA

    Confirmation statement made on Sep 15, 2022 with updates

    4 pagesCS01

    Current accounting period extended from Sep 30, 2022 to Dec 31, 2022

    1 pagesAA01

    Director's details changed for Mr Ceri James Matthews on May 12, 2022

    2 pagesCH01

    Appointment of Mr Ceri James Matthews as a director on Apr 28, 2022

    2 pagesAP01

    Termination of appointment of Tobias Blaise Richardson as a director on Apr 27, 2022

    1 pagesTM01

    Resolutions

    Resolutions
    3 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of allotment of securities

    RES10
    capital

    Resolution of removal of pre-emption rights

    RES11
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Memorandum and Articles of Association

    37 pagesMA

    Particulars of variation of rights attached to shares

    2 pagesSH10

    Appointment of Mr Tobias Blaise Richardson as a director on Dec 21, 2021

    2 pagesAP01

    Statement of capital following an allotment of shares on Dec 22, 2021

    • Capital: GBP 7,478.41
    4 pagesSH01

    Statement of capital following an allotment of shares on Dec 21, 2021

    • Capital: GBP 9.99
    4 pagesSH01

    Notification of Royal Marsden Nhs Foundation Trust as a person with significant control on Dec 21, 2021

    2 pagesPSC03

    Notification of The Institute of Cancer Research as a person with significant control on Dec 21, 2021

    2 pagesPSC02

    Cessation of Matthew David Blackledge as a person with significant control on Dec 21, 2021

    1 pagesPSC07

    Appointment of Mr Paul Francis Walter Norris as a director on Dec 21, 2021

    2 pagesAP01

    Appointment of Ms Sofia Alda Colas-Allen as a director on Dec 21, 2021

    2 pagesAP01

    Appointment of Mr Marcus James Thorman as a director on Dec 21, 2021

    2 pagesAP01

    Who are the officers of DIAFORA MEDICAL LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    BLACKLEDGE, Matthew David, Dr
    Fulham Road
    SW3 6JJ London
    203
    United Kingdom
    Director
    Fulham Road
    SW3 6JJ London
    203
    United Kingdom
    United KingdomBritish287347320001
    COLAS-ALLEN, Sofia Alda
    Fulham Road
    SW3 6JJ London
    203
    United Kingdom
    Director
    Fulham Road
    SW3 6JJ London
    203
    United Kingdom
    EnglandBritish284743160002
    MATHEWS, Ceri James
    123 Old Brompton Road
    SW7 3RP London
    Icr
    England
    Director
    123 Old Brompton Road
    SW7 3RP London
    Icr
    England
    EnglandEnglish295270300002
    NORRIS, Paul Francis Walter
    Old Brompton Road
    SW7 3RP London
    Icr, 123
    England
    Director
    Old Brompton Road
    SW7 3RP London
    Icr, 123
    England
    EnglandBritish114228920001
    ZAREMBA-TYMIENIECKA, Karolina Elizabeth
    Fulham Road
    SW3 6JJ London
    203
    United Kingdom
    Director
    Fulham Road
    SW3 6JJ London
    203
    United Kingdom
    EnglandBritish323307680001
    RICHARDSON, Tobias Blaise
    Old Brompton Road
    SW7 3RP London
    Icr, 123
    England
    Director
    Old Brompton Road
    SW7 3RP London
    Icr, 123
    England
    EnglandBritish290896260001
    THORMAN, Marcus James
    Fulham Road
    SW3 6JJ London
    203
    United Kingdom
    Director
    Fulham Road
    SW3 6JJ London
    203
    United Kingdom
    EnglandBritish237028560001

    Who are the persons with significant control of DIAFORA MEDICAL LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Royal Marsden Nhs Foundation Trust
    Fulham Road
    SW3 6JJ London
    203
    England
    Dec 21, 2021
    Fulham Road
    SW3 6JJ London
    203
    England
    No
    Legal FormPublic Benefit Corporation
    Legal AuthorityNational Health Service Act 2006
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    The Institute Of Cancer Research
    Old Brompton Road
    SW7 3RP London
    123
    England
    Dec 21, 2021
    Old Brompton Road
    SW7 3RP London
    123
    England
    No
    Legal FormCompany Limited By Guarantee
    Country RegisteredEngland
    Legal AuthorityCompanies Act 2006
    Place RegisteredEngland And Wales
    Registration Number00534147
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    Dr Matthew David Blackledge
    Fulham Road
    SW3 6JJ London
    203
    United Kingdom
    Sep 16, 2021
    Fulham Road
    SW3 6JJ London
    203
    United Kingdom
    Yes
    Nationality: British
    Country of Residence: United Kingdom
    Natures of Control
    • The person holds, directly or indirectly, more than 50% but not more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 50% but not more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0